ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 28 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,000 | +100.0% | 11,700 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | -50.0% | 11,700 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +14.3% | 11,700 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | -50.0% | 11,700 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | -17.6% | 11,700 | 0.0% | 0.00% | – |
| Q1 2017 | $17,000 | +54.5% | 11,700 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | -31.2% | 11,700 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | -23.8% | 11,700 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | -12.5% | 11,700 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -36.8% | 11,700 | 0.0% | 0.00% | – |
| Q4 2015 | $38,000 | +81.0% | 11,700 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -32.3% | 11,700 | 0.0% | 0.00% | – |
| Q2 2015 | $31,000 | -95.5% | 11,700 | -95.8% | 0.00% | – |
| Q1 2015 | $695,000 | -45.0% | 281,858 | +31.2% | 0.00% | – |
| Q4 2014 | $1,263,000 | -9.1% | 214,839 | +3.6% | 0.00% | – |
| Q3 2014 | $1,389,000 | +4.6% | 207,440 | +12.9% | 0.00% | – |
| Q2 2014 | $1,328,000 | – | 183,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8,343,716 | $2,053,000 | 2.58% |
| Sio Capital Management, LLC | 4,935,250 | $1,214,000 | 0.29% |
| Endurant Capital Management LP | 2,481,355 | $610,000 | 0.24% |
| Fosun International Ltd | 596,752 | $147,000 | 0.01% |
| Malaga Cove Capital, LLC | 30,000 | $7,000 | 0.01% |
| Summit X, LLC | 35,000 | $8,000 | 0.00% |
| ARDSLEY ADVISORY PARTNERS LP | 75,000 | $19,000 | 0.00% |
| Fosun International Ltd | 168,851 | $42,000 | 0.00% |
| INTRUST BANK NA | 40,000 | $10,000 | 0.00% |
| Cetera Advisor Networks LLC | 142,500 | $49,000 | 0.00% |